MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 377 filers reported holding MEDIVATION INC in Q1 2015. The put-call ratio across all filers is 0.42 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $2,178,000 | +23.5% | 36,118 | -5.9% | 0.02% | +20.0% |
| Q1 2016 | $1,764,000 | -7.6% | 38,373 | -2.9% | 0.02% | -6.2% |
| Q4 2015 | $1,910,000 | +13.9% | 39,511 | +0.1% | 0.02% | +6.7% |
| Q3 2015 | $1,677,000 | -25.7% | 39,468 | +99.7% | 0.02% | -16.7% |
| Q2 2015 | $2,257,000 | -15.7% | 19,761 | -4.7% | 0.02% | -18.2% |
| Q1 2015 | $2,676,000 | +21.9% | 20,736 | -5.9% | 0.02% | +22.2% |
| Q4 2014 | $2,195,000 | +0.6% | 22,031 | -0.2% | 0.02% | -5.3% |
| Q3 2014 | $2,182,000 | +21.1% | 22,073 | -5.6% | 0.02% | +26.7% |
| Q2 2014 | $1,802,000 | +5.0% | 23,376 | -12.3% | 0.02% | 0.0% |
| Q1 2014 | $1,716,000 | +0.8% | 26,661 | -0.0% | 0.02% | 0.0% |
| Q4 2013 | $1,702,000 | +6.6% | 26,670 | +0.2% | 0.02% | 0.0% |
| Q3 2013 | $1,596,000 | +22.1% | 26,627 | +0.2% | 0.02% | +25.0% |
| Q2 2013 | $1,307,000 | – | 26,571 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,484,101 | $148,897,000 | 79.45% |
| BB BIOTECH AG | 1,449,706 | $86,895,000 | 4.73% |
| SECTORAL ASSET MANAGEMENT INC | 1,013,529 | $60,751,000 | 2.92% |
| Orbimed Advisors | 2,284,500 | $136,933,000 | 2.44% |
| Archipel Asset Management AB | 191,016 | $11,449,000 | 2.35% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 147,060 | $8,815,000 | 1.43% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 450,000 | $26,973,000 | 1.32% |
| QVT Financial LP | 305,128 | $18,289,000 | 1.24% |
| Bain Capital Public Equity Management, LLC | 825,687 | $49,492,000 | 1.24% |
| Tradeworx Inc. | 44,484 | $2,666,000 | 1.22% |